These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 2735275

  • 21. [A study of prostatic tissue levels of ceftizoxime, cefoperazone and cefotaxime].
    Ikeda S, Ishibashi A, Koshiba K.
    Hinyokika Kiyo; 1984 Aug; 30(8):1135-42. PubMed ID: 6083722
    [Abstract] [Full Text] [Related]

  • 22. [A study on the levels of cefoperazone in urological organs].
    Fukatsu H, Waki M, Hatano Y, Hiraiwa S, Kikuchi T, Muramatsu T, Yamada Y, Nishikawa E, Satoh T, Honda N.
    Hinyokika Kiyo; 1985 Jun; 31(6):1085-91. PubMed ID: 4061208
    [Abstract] [Full Text] [Related]

  • 23. [Experimental and clinical studies of sulbactam/cefoperazone in pediatric field].
    Nakashima T, Ueda S, Hayakawa F, Miyachi Y, Hakamada S, Kuno K.
    Jpn J Antibiot; 1984 Oct; 37(10):1846-58. PubMed ID: 6094864
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Enhancement of susceptibility of sulbactam/cefoperazone-treated bacteria to phagocytes].
    Tanaka T, Iida-Tanaka K, Irino S.
    Jpn J Antibiot; 1991 Jul; 44(7):732-5. PubMed ID: 1886199
    [Abstract] [Full Text] [Related]

  • 28. [Clinical evaluation of sulbactam/cefoperazone in the pediatric infections].
    Meguro H, Tajima T, Nonaka C, Mashiko J, Fujii R, Arimasu O.
    Jpn J Antibiot; 1984 Oct; 37(10):1821-30. PubMed ID: 6094862
    [Abstract] [Full Text] [Related]

  • 29. [Clinical evaluation of sulbactam/cefoperazone in the field of obstetrics and gynecology].
    Yabuki Y, Asamoto A, Hoshiba T.
    Jpn J Antibiot; 1984 Oct; 37(10):1973-6. PubMed ID: 6094876
    [Abstract] [Full Text] [Related]

  • 30. Bioequivalence study of the two 1.5 g cefoperazone and sulbactam IM injections in Thai healthy male volunteers.
    Kaewvichit S, Yotsawimonwat S, Taesotikul W, Niwatananun W, Duangrat C, Wongsinsup C, Thongsawat S, Salee P.
    J Med Assoc Thai; 2008 Nov; 91(11):1760-4. PubMed ID: 19127801
    [Abstract] [Full Text] [Related]

  • 31. [Clinical evaluation of sulbactam/cefoperazone for infections in the field of obstetrics and gynecology].
    Chimura T, Inoue K, Morisaki N.
    Jpn J Antibiot; 1984 Oct; 37(10):1928-33. PubMed ID: 6094871
    [Abstract] [Full Text] [Related]

  • 32. [Clinical evaluation of sulbactam/cefoperazone for infections during the chemotherapy of hematologic malignancy].
    Kawai Y, Ueda T, Iwasaki H, Nakamura T.
    Jpn J Antibiot; 1994 Sep; 47(9):1196-201. PubMed ID: 7990260
    [Abstract] [Full Text] [Related]

  • 33. [Clinical evaluation of sulbactam/cefoperazone for severe infections associated with hematological disorders].
    Kitamura K, Takaku F, Miyazaki T, Miura, Mizoguchi H, Saito H, Masaoka T, Kimura I, Niho Y.
    Jpn J Antibiot; 1991 Sep; 44(9):979-86. PubMed ID: 1960859
    [Abstract] [Full Text] [Related]

  • 34. [Clinical evaluation of combination therapy of sulbactam/cefoperazone and aminoglycoside in respiratory tract infections].
    Sukoh M, Inoue T, Morita Y, Ito K, Togano Y, Yamanaka K, Hirose S, Takahashi T, Mita S, Mano K.
    Jpn J Antibiot; 1994 Feb; 47(2):170-80. PubMed ID: 8151910
    [Abstract] [Full Text] [Related]

  • 35. [Clinical studies of sulbactam/cefoperazone therapy in pediatric bacterial infections].
    Nakamura A, Himi K, Matsumura C, Suzuki H, Kurosaki T, Sugaya N, Terashima I, Uehara S.
    Jpn J Antibiot; 1984 Oct; 37(10):1793-800. PubMed ID: 6094859
    [Abstract] [Full Text] [Related]

  • 36. [Clinical experience with chemotherapy using sulbactam/cefoperazone for severe infections accompanying malignant hematological disorders].
    Fujii Y, Ayame H, Inoue H, Fujita N, Miyoshi K, Murano K, Hatao K, Yaga K, Kaku K, Kaneko T.
    Jpn J Antibiot; 1990 Jun; 43(6):1143-51. PubMed ID: 2232145
    [Abstract] [Full Text] [Related]

  • 37. [Experience with sulbactam/cefoperazone in the field of obstetrics and gynecology].
    Kohara T, Matsui Y, Noda M, Hirai S, Iida S.
    Jpn J Antibiot; 1984 Oct; 37(10):1934-8. PubMed ID: 6094872
    [Abstract] [Full Text] [Related]

  • 38. [Clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
    Ikushima Y, Kobayashi H, Matsumoto S, Shirakawa K.
    Jpn J Antibiot; 1984 Nov; 37(11):2251-5. PubMed ID: 6098719
    [Abstract] [Full Text] [Related]

  • 39. [Clinical evaluation of sulbactam/cefoperazone in obstetric and gynecological infection].
    Domon H, Kodama M, Sato H, Shimizu T, Washizuka N, Eto M.
    Jpn J Antibiot; 1984 Oct; 37(10):1925-7. PubMed ID: 6094870
    [Abstract] [Full Text] [Related]

  • 40. [Treatment with sulbactam/cefoperazone of severe infections in patients with hematological disorders].
    Ohno R, Hotta T, Ogura M, Ohnishi K, Morishita T, Murate T, Okumura M, Tanimoto M, Inoue C, Hamaguchi M.
    Jpn J Antibiot; 1989 Aug; 42(8):1713-9. PubMed ID: 2810734
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.